Fulgent Genetics, Inc 10-Q for FY2026 Q3
Fulgent Genetics, Inc. (FLGT)
10-Q
2026-11-05
For: 2026-09-30
View Original
Added on
November 05, 2026
About this 10-Q
Fulgent Genetics, Inc filed this 10-Q on November 5, 2026, covering the quarter ended September 30, 2026 (FY2026 Q3).
Fulgent Genetics reported revenue of $90.4 million for the three months ended September 30, 2026, up 8%, while gross profit fell $3.6 million, or 10%, as billing transition delays and lower collections pressured margin. AI summary
Headline figures
Quarter ended September 30, 2026, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $90.41M
- up 7.5% from $84.07M a year earlier
- Net loss
- $13.15M
- compared with a net loss of $6.61M a year earlier